University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Ultrasound and CT to Measure Muscle in Hip OA

Withdrawn

Conditions: Hip Osteoarthritis

First Posted Date: 2019-08-19

Last Posted Date: 2021-05-04

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT04061499

Locations: 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia, Adult
Acute Myeloid Leukemia Recurrent
Acute Myeloid Leukemia, Relapsed, Adult

Interventions: Drug: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO)

First Posted Date: 2019-08-08

Last Posted Date: 2024-04-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 39

Registration Number: NCT04050280

Locations: 🇺🇸
Larissa Sanglard, Baltimore, Maryland, United States

Itraconazole Oral Absorption

Phase 4

Completed

Conditions: Fungal Infection

Interventions: Drug: fast itraconazole tablet
Drug: medium itraconazole tablet
Drug: slow itraconazole tablet
Drug: oral itraconazole solution

First Posted Date: 2019-07-29

Last Posted Date: 2023-10-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 17

Registration Number: NCT04035187

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Home Exercise Program for Homebound Older Adults

Not Applicable

Completed

Conditions: Aging

Interventions: Behavioral: HEX

First Posted Date: 2019-07-26

Last Posted Date: 2024-12-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 19

Registration Number: NCT04034888

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Effects of Early Community Services on Child and Family Development

Not Applicable

Active, not recruiting

Conditions: Child Development

Interventions: Other: Nurse Home Visiting Program

First Posted Date: 2019-07-15

Last Posted Date: 2020-10-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 277

Registration Number: NCT04019977

Locations: 🇺🇸
UMaryland, Baltimore, Maryland, United States
🇺🇸
Sinai Hospital, Baltimore, Maryland, United States

Youth Opioid Recovery Support: Improving Care Systems

Not Applicable

Completed

Conditions: Opioid-Related Disorders

Interventions: Behavioral: Youth Opioid Recovery Support service model

First Posted Date: 2019-07-10

Last Posted Date: 2022-02-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 44

Registration Number: NCT04015115

Locations: 🇺🇸
Mountain Manor Treatment Center, Baltimore, Maryland, United States

The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia

Phase 1

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder

Interventions: Drug: Placebo
Drug: N-acetylcysteine (NAC)
Drug: Tryptophan

First Posted Date: 2019-07-09

Last Posted Date: 2024-11-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 88

Registration Number: NCT04013555

Locations: 🇺🇸
Maryland Psychiatric Research Center (MPRC) ; the Treatment Research Program (TRP), Catonsville, Maryland, United States

Cigarette Smoking in Smokers With and Without Schizophrenia

Not Applicable

Recruiting

Conditions: Schizophrenia
Tobacco Dependence

Interventions: Combination Product: Sampling Research Cigarettes

First Posted Date: 2019-06-27

Last Posted Date: 2022-10-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 90

Registration Number: NCT04001114

Locations: 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination with Trivalent Invasive Salmonella Disease Vaccine

Phase 1

Completed

Conditions: Risk Reduction

Interventions: Biological: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
Biological: Trivalent Invasive Salmonella Disease Vaccine (12 µg)
Biological: Trivalent Invasive Salmonella Disease Vaccine (25 µg)
Biological: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerated dose among Cohorts A-C)
Other: Placebo

First Posted Date: 2019-06-11

Last Posted Date: 2024-11-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 96

Registration Number: NCT03981952

Locations: 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

Blood Donor CVD 5000

Phase 4

Recruiting

Conditions: Risk Reduction

Interventions: Drug: Vivotif Typhoid Oral Vaccine

First Posted Date: 2019-06-03

Last Posted Date: 2024-02-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 150

Registration Number: NCT03971669

Locations: 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy